Get 20% lifetime commission for referring investors to digrin.com
here.
Annexon, Inc. (ANNX) Financials
ANNX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 246.1 million | 60.0 million |
| March 31, 2026 | 262.9 million | 58.4 million |
| Dec. 31, 2025 | 277.6 million | 65.9 million |
| Sept. 30, 2025 | 229.1 million | 67.7 million |
ANNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -48.1 million | 4.8 million |
| March 31, 2026 | -46.8 million | 4.2 million |
| Dec. 31, 2025 | -45.9 million | 3.3 million |
| Sept. 30, 2025 | -52.4 million | 3.8 million |
ANNX Net Income
No data available :(
ANNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 209.2 million | - | 24.7 million |
| March 31, 2026 | 225.0 million | - | 25.4 million |
| Dec. 31, 2025 | 238.3 million | - | 26.2 million |
| Sept. 30, 2025 | 188.7 million | - | 26.9 million |
ANNX Shares Outstanding
ANNX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 137000 | 46.6 million | 10.6 million | - |
| March 31, 2026 | - | 35.8 million | 10.3 million | - |
| Dec. 31, 2025 | - | 42.7 million | 8.2 million | - |
| Sept. 30, 2025 | 48000 | 49.7 million | 7.3 million | - |
ANNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 957000 |
| Dec. 31, 2025 | - | 945000 |
| Sept. 30, 2025 | - | - |
ANNX
Price: $3.41
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 124730
Market Capitalization: 686.5 million